TherapeuticsMD (TXMD) Non Operating Income (2010 - 2026)

TherapeuticsMD has reported Non Operating Income for 17 years, with the latest figure at $826000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income rose 34.75% year-over-year to $826000.0; the trailing twelve-month figure through Mar 2026 stood at $4.0 million (up 8.1% YoY), and the FY2025 full-year result was $3.7 million, down 0.85% from the prior year.
• Non Operating Income for Q1 2026 stood at $826000.0, down from $972000.0 in the prior quarter.
• The five-year high for Non Operating Income was $1.7 million in Q2 2024, with the low at -$22.8 million in Q1 2022.
• Historically, Non Operating Income has averaged -$834764.7 across 5 years, with a median of $357000.0 in 2023.
• Annual changes were most pronounced in 2022 — Non Operating Income slumped 125.55% — and 2024, when it soared 2898.28%.
• TherapeuticsMD's Non Operating Income stood at $11000.0 in 2022, then soared by 145.45% to $27000.0 in 2023, then soared by 2622.22% to $735000.0 in 2024, then surged by 32.24% to $972000.0 in 2025, then retreated by 15.02% to $826000.0 in 2026.
• The last three Non Operating Income figures came in at $826000.0 (Q1 2026), $972000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.